Keeping Your Nose in Front

Pharmaceutical developers are waking up to the idea that drug delivery via the nose could offer advantages for their target product, patient population, and indication. Traditionally, many formulators tend to think of oral dosing first – their comfort zone – followed by an injectable, if the oral route is not suitable. Other routes of delivery, such as nasal sprays, were typically only considered when all else failed.

Thanks to an increased focus on patient needs over recent years, nasal delivery is now moving to the forefront of formulators’ psyches – notably, at the very start of the development process. Development teams are establishing target product profiles early on and recognizing the benefits of establishing the needs of prescribers and patients from the outset.